Stocks Health care AGL
NYSE · Health careagilon health, inc. (AGL)
agilon health, inc. brought in $6B of revenue over the twelve months to September 30, 2026, up 2.0% from a year earlier. It posted a net loss of $87.1M. In fiscal 2025 capital spending exceeded operating cash flow by $119M. At September 30, 2026 it held $174.4M in cash against $30.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 4, 2026.
Key facts about agilon health, inc.
- Net worth
- agilon health, inc. has a market value (market cap) of $1.9B at the latest share price, and shareholders' equity of $280.9M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $5.9B (-2.1% year on year), with a net loss of $391.3M. Over the 12 months to September 30, 2026: revenue $6B, net loss $87.1M.
- Cash flow
- In fiscal 2025 operations used $105.8M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 4, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- agilon health, inc.'s next report is expected around February 24, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What agilon health, inc. does
agilon health, inc. is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on NYSE under the ticker AGL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $5.9B | -$391.3M | n/a | -$119M |
| 2024 | $6.1B | -$260.2M | n/a | -$71M |
| 2023 | $4.3B | -$262.6M | n/a | -$172M |
| 2022 | $2.4B | -$106.6M | n/a | -$146.2M |
| 2021 | $1.5B | -$406.5M | n/a | -$154.7M |
| 2021 | $1.2B | -$60.1M | n/a | -$55M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where AGL ranks in Health care
Latest SEC filings
What agilon health, inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 4, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 5.9% to $1.5B versus the same quarter last year; diluted EPS $1.97 versus -$6.65.
- November 4, 2026
- August 12, 2026Passive stake changed SCHEDULE 13G/A
- August 11, 2026Passive stake changed SCHEDULE 13G/A
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 7.2% to $1.5B versus the same quarter last year; diluted EPS $1.04 versus -$6.31.
- August 5, 2026
- July 22, 2026
- June 3, 2026
- May 14, 2026Passive stake (5% or more) SCHEDULE 13G
- May 13, 2026Passive stake (5% or more) SCHEDULE 13G
Insider trades
What the people running agilon health, inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 16, 2026 | Gertsch TimothyChief Accounting Officer | Shares withheld for tax | 17 | $1.6K |
| August 1, 2026 | Zamore DeniseChief Legal Officer | Shares withheld for tax | 37 | $3.4K |
| July 1, 2026 | Schwaneke Jeffrey A.Chief Financial Officer | Shares withheld for tax | 2,311 | $258.2K |
| June 2, 2026 | Battaglia SilvanaDirector | Received as pay | 2,133 | - |
| June 2, 2026 | Mansukani SharadDirector | Received as pay | 2,133 | - |
| June 2, 2026 | Mckenzie DianaDirector | Received as pay | 2,133 | - |
| June 2, 2026 | McLoughlin KarenDirector | Received as pay | 2,133 | - |
| June 2, 2026 | Williams Ronald ADirector | Received as pay | 2,133 | - |
Who owns AGL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| North Peak Capital Management, LLC13G, passive with 7 related filers | 9.5% | November 13, 2025 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 179 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Clayton, Dubilier & Rice, LLC | 4,000,000 | 0 |
| Morgan Stanley | 2,011,196 | -88,255 |
| North Peak Capital Management, LLC | 1,485,066 | -60,471 |
| BlackRock, Inc. | 1,146,520 | +273,356 |
| Aqr Capital Management LLC | 692,541 | -282,356 |
| Goldman Sachs Group Inc | 686,792 | -375,444 |
| Vanguard Capital Management LLC | 525,328 | -13,208 |
| Marshall Wace, Llp | 468,293 | new |
| Durable Capital Partners LP | 440,642 | new |
| D. E. Shaw & Co., Inc. | 390,149 | -352,069 |
| Charles Schwab Investment Management Inc | 348,960 | -15,539 |
| Geode Capital Management, LLC | 314,165 | +48,053 |
| State Street Corp | 280,126 | +26,422 |
| Jane Street Group, LLC | 273,393 | +258,280 |
| Rock Springs Capital Management LP | 262,600 | +2,600 |
| Nuveen, LLC | 229,071 | +197,075 |
| Renaissance Technologies LLC | 152,214 | +3,171 |
| Invesco Ltd. | 133,144 | +92,608 |
| Vanguard Portfolio Management LLC | 128,328 | +17,493 |
| Two Sigma Investments, LP | 125,713 | +26,361 |
Insiders
12 insiders reported holding 945,258 shares in total, about $107.9M at the last price.
| Holder | Shares |
|---|---|
| O'Rourke Timothy PatrickCEO & President, Director | 320,000 |
| Williams Ronald ADirector | 149,141 |
| Schwaneke Jeffrey A.Chief Financial Officer | 138,031 |
| Shaker BenjaminChief Markets Officer | 122,850 |
| Zamore DeniseChief Legal Officer | 66,075 |
| Mansukani SharadDirector | 56,242 |
| Venkatachaliah GirishChief Technology Officer | 38,236 |
| Wulf John WilliamDirector | 16,765 |
| Gertsch TimothyChief Accounting Officer | 14,152 |
| McLoughlin KarenDirector | 8,207 |
Questions about AGL
What does agilon health, inc. do?
agilon health, inc. is a company in the Health care sector, listed on NYSE as AGL. Its shares trade on NYSE under the ticker AGL.
What is agilon health, inc.'s net worth?
agilon health, inc. has a market value (market cap) of $1.9B at the latest share price, and shareholders' equity of $280.9M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is agilon health, inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $87.1M on revenue of $6B.
How much revenue does agilon health, inc. make?
Over the twelve months to September 30, 2026 agilon health, inc. reported revenue of $6B. That is 2.0% more than a year earlier.
When did agilon health, inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 4, 2026. It covers the period to September 30, 2026.
When is agilon health, inc.'s next earnings report?
agilon health, inc.'s next report is expected around February 24, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare AGL with
Follow AGL
Get an email when agilon health, inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values agilon health, inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.